Pentwater Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Pentwater Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,000	Closed	-$996K	–	186
2022 Q4	$996K	Buy	+30,000	New	+$966K	0.02%	99

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pentwater Capital Management's VIVO Position: Q1 2023 in Review

Pentwater Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 30,000 shares — an estimated $996K sold.

Pentwater Capital Management first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $996K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Pentwater Capital Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Pentwater Capital Management sold 30,000 Meridian Bioscience Inc shares in Q1 2023, an estimated $996K.
Pentwater Capital Management first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Pentwater Capital Management's Meridian Bioscience Inc position peaked at $996K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Pentwater Capital Management's 13F filing for Q1 2023, filed 15 May 2023.